We recommend an ACEi be used in all patients as soon as safely possible after a myocardial infarction (MI) and be continued indefinitely if EF <40 % or if HF complicates a MI. (Recommendation Strong, Quality High).

We recommend ACEi be used in all asymptomatic patients with an EF <35 %. (Recommendation Strong, Quality Moderate).

We recommend ACEi be used in all symptomatic HF patients and EF <40 %. (Recommendation Strong, Quality High).